Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models.

Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson’s disease models.
Related ArticlesDevelopment of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models. Commun Biol. 2021 Feb 19;4(1):232 Authors: Jin JW, Fan X, Del Cid-Pellitero E, Liu XX, Zhou L, Dai C, Gibbs E, He W, Li H, Wu X, Hill A, Leavitt BR, Cashman N, Liu L, Lu J, Durcan TM, Dong Z, Fon EA, Wang ... read more
Source: PubMedPublished on 2021-02-21